Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Disease Control and Prevention [30Day-17-0666]
 The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. CDC previously published a “Proposed Data Collection Submitted for Public Comment and Recommendations” notice on May 30, 2017 to obtain comments from the public and affected agencies. CDC received one comment related to the first notice. The purpose of this notice is to allow an additional 30 days for public comments. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, 
                    *e.g.,*
                     permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639-7570 or send an email to 
                    *omb@cdc.gov.*
                     Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW., Washington, DC 20503 or by fax to (202) 395-5806. Provide written comments within 30 days of notice publication. Proposed Project National Healthcare Safety Network (NHSN) (OMB No. 0920-0666), exp. 11/30/2019—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Healthcare Safety Network (NHSN) is a system designed to accumulate, exchange, and integrate relevant information and resources among private and public stakeholders to support local and national efforts to protect patients and promote healthcare safety. Specifically, CDC uses the data to 
                    ( print page 43986)
                    determine the magnitude of various healthcare-associated adverse events and trends in the rates of these events among patients and healthcare workers with similar risks. CDC will use the data to detect changes in the epidemiology of adverse events resulting from new and current medical therapies and changing risks. The NHSN currently consists of five components: Patient Safety, Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility (LTCF), and Dialysis. CDC will release the NHSN “Outpatient Procedure Component” in 2018. CDC's request for additional user feedback and support from outside partners delayed development of this component. After receiving user feedback and internal review feedback, CDC made changes to six facility surveys. For the annual facility surveys, CDC amended, removed, or added questions and response options to fit the survey's evolving uses. In addition, CDC and its partners use the surveys to help intelligently interpret the other data elements reported into NHSN. Currently, the surveys are used to appropriately risk adjust the numerator and denominator data entered into NHSN while also guiding decisions on future division priorities for prevention. Further, two new forms were added to expand NHSN surveillance to enhance data collection by Ambulatory Surgical Centers to identify areas where prevention of SSIs may be improved. CDC modified an additional 14 forms within the Hemovigilance module to streamline data collection/entry for adverse reaction events. Overall, CDC has made minor revisions to a total of 44 forms within the package to clarify and/or update surveillance definitions, increase or decrease the number of reporting facilities, and adding 2 new forms. The previously approved NHSN information collection package included 70 individual collection forms; the current revision request includes 72 forms. The reporting burden will increase by 811,985 hours, for a total of 5,922,953 hours. Estimated Annualized Burden Hours
Type of respondent
Form No. & name
Number of
                             respondents
Number of
                             responses per 
                             respondent
Average
                             burden per 
                             response 
                             (hours)Registered Nurse (Infection Preventionist)
57.100 NHSN Registration Form
2,000
1
5/60Registered Nurse (Infection Preventionist)
57.101 Facility Contact Information
2,000
1
10/60Registered Nurse (Infection Preventionist)
57.103 Patient Safety Component—Annual Hospital Survey
5,000
1
55/60Registered Nurse (Infection Preventionist)
57.105 Group Contact Information
1,000
1
5/60Registered Nurse (Infection Preventionist)
57.106 Patient Safety Monthly Reporting Plan
6,000
12
15/60Registered Nurse (Infection Preventionist)
57.108 Primary Bloodstream Infection (BSI)
6,000
44
30/60Registered Nurse (Infection Preventionist)
57.111 Pneumonia (PNEU)
6,000
72
30/60Registered Nurse (Infection Preventionist)
57.112 Ventilator-Associated Event
6,000
144
25/60Registered Nurse (Infection Preventionist)
57.113 Pediatric Ventilator-Associated Event (PedVAE)
2,000
120
25/60Registered Nurse (Infection Preventionist)
57.114 Urinary Tract Infection (UTI)
6,000
40
20/60Registered Nurse (Infection Preventionist)
57.115 Custom Event
2,000
91
35/60Staff RN
57.116 Denominators for Neonatal Intensive Care Unit (NICU)
6,000
12
4Staff RN
57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC)
6,000
9
5Staff RN
57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA)
6,000
60
5Registered Nurse (Infection Preventionist)
57.120 Surgical Site Infection (SSI)
6,000
36
35/60Staff RN
57.121 Denominator for Procedure
6,000
540
10/60Laboratory Technician
57.123 Antimicrobial Use and Resistance (AUR)—Microbiology Data Electronic Upload Specification Tables
6,000
12
5/60Pharmacist
57.124 Antimicrobial Use and Resistance (AUR)—Pharmacy Data Electronic Upload Specification Tables
6,000
12
5/60Registered Nurse (Infection Preventionist)
57.125 Central Line Insertion Practices Adherence Monitoring
100
100
25/60Registered Nurse (Infection Preventionist)
57.126 MDRO or CDI Infection Form
6,000
72
30/60Registered Nurse (Infection Preventionist)
57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring
6,000
24
15/60Registered Nurse (Infection Preventionist)
57.128 Laboratory-identified MDRO or CDI Event
6,000
240
20/60Registered Nurse (Infection Preventionist)
57.129 Adult Sepsis
50
250
25/60Registered Nurse (Infection Preventionist)
57.137 Long-Term Care Facility Component—Annual Facility Survey
2,600
1
2( print page 43987)Registered Nurse (Infection Preventionist)
57.138 Laboratory-identified MDRO or CDI Event for LTCF
2,600
12
15/60Registered Nurse (Infection Preventionist)
57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF
2,600
12
10/60Registered Nurse (Infection Preventionist)
57.140 Urinary Tract Infection (UTI) for LTCF
2,600
14
30/60Registered Nurse (Infection Preventionist)
57.141 Monthly Reporting Plan for LTCF
2,600
12
5/60Registered Nurse (Infection Preventionist)
57.142 Denominators for LTCF Locations
2,600
12
4Registered Nurse (Infection Preventionist)
57.143 Prevention Process Measures Monthly Monitoring for LTCF
2,600
12
5/60Registered Nurse (Infection Preventionist)
57.150 LTAC Annual Survey
400
1
55/60Registered Nurse (Infection Preventionist)
57.151 Rehab Annual Survey
1,000
1
55/60Occupational Health RN/Specialist
57.200 Healthcare Personnel Safety Component Annual Facility Survey
50
1
8Occupational Health RN/Specialist
57.203 Healthcare Personnel Safety Monthly Reporting Plan
17,000
1
5/60Occupational Health RN/Specialist
57.204 Healthcare Worker Demographic Data
50
200
20/60Occupational Health RN/Specialist
57.205 Exposure to Blood/Body Fluids
50
50
1Occupational Health RN/Specialist
57.206 Healthcare Worker Prophylaxis/Treatment
50
30
15/60Laboratory Technician
57.207 Follow-Up Laboratory Testing
50
50
15/60Occupational Health RN/Specialist
57.210 Healthcare Worker Prophylaxis/Treatment-Influenza
50
50
10/60Medical/Clinical Laboratory Technologist
57.300 Hemovigilance Module Annual Survey
500
1
2Medical/Clinical Laboratory Technologist
57.301 Hemovigilance Module Monthly Reporting Plan
500
12
1/60Medical/Clinical Laboratory Technologist
57.303 Hemovigilance Module Monthly Reporting Denominators
500
12
1.17Medical/Clinical Laboratory Technologist
57.305 Hemovigilance Incident
500
10
10/60Medical/Clinical Laboratory Technologist
57.306 Hemovigilance Module Annual Survey—Non-acute care facility
200
1
35/60Medical/Clinical Laboratory Technologist
57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction
500
4
20/60Medical/Clinical Laboratory Technologist
57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction
500
4
20/60Medical/Clinical Laboratory Technologist
57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction
500
1
20/60Medical/Clinical Laboratory Technologist
57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction
500
2
20/60Medical/Clinical Laboratory Technologist
57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction
500
4
20/60Medical/Clinical Laboratory Technologist
57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction
500
1
20/60Medical/Clinical Laboratory Technologist
57.313 Hemovigilance Adverse Reaction—Infection
500
1
20/60Medical/Clinical Laboratory Technologist
57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura
500
1
20/60Medical/Clinical Laboratory Technologist
57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea
500
1
20/60Medical/Clinical Laboratory Technologist
57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease
500
1
20/60Medical/Clinical Laboratory Technologist
57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury
500
1
20/60Medical/Clinical Laboratory Technologist
57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload
500
2
20/60Medical/Clinical Laboratory Technologist
57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction
500
1
20/60Medical/Clinical Laboratory Technologist
57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction
500
1
20/60Medical/Clinical Laboratory Technologist
57.400 Patient Safety Component—Annual Facility Survey
5,000
1
5/60( print page 43988)Staff RN
57.401 Outpatient Procedure Component—Monthly Reporting Plan
5,000
12
15/60Staff RN
57.402 Outpatient Procedure Component—Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic Timing Event
5,000
25
40/60Staff RN
57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic Timing Event
5,000
12
40/60Staff RN
57.404 Outpatient Procedure Component—Annual Facility Survey
5,000
540
10/60Registered Nurse (Infection Preventionist)
57.405 Outpatient Procedure Component—Surgical Site (SSI) Event
5,000
36
35/60Staff RN
57.500 Outpatient Dialysis Center Practices Survey
7,000
1
2.0Registered Nurse (Infection Preventionist)
57.501 Dialysis Monthly Reporting Plan
7,000
12
5/60Staff RN
57.502 Dialysis Event
7,000
60
25/60Staff RN
57.503 Denominator for Outpatient Dialysis
7,000
12
10/60Staff RN
57.504 Prevention Process Measures Monthly Monitoring for Dialysis
2,000
12
1.25Staff RN
57.505 Dialysis Patient Influenza Vaccination
325
75
10/60Staff RN
57.506 Dialysis Patient Influenza Vaccination Denominator
325
5
10/60Staff RN
57.507 Home Dialysis Center Practices Survey
350
1
30/60
 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention.


[FR Doc. 2017-20009 Filed 9-19-17; 8:45 am] BILLING CODE 4163-18-P